We always think of our customers with an open mind
Press Release
AI Cervical Cancer Screening System: 'CerviCARE® AI', Proven Utility at Mongolian Medical IT Seminar
Author
엔티엘헬스케어
Date
2024-02-14 11:13
Views
116
On January 13, a medical IT seminar was held in Mongolia as part of a project for regular cervical cancer screening and early prevention.
The artificial intelligence (AI) cervical cancer screening system, 'CerviCARE® AI', provided worldwide by NTL Healthcare, was a major topic of discussion.
The seminar was successfully held with the attendance of the director of the National Cancer Center and current member of the National Assembly, Chinburen,
the head of the ruling party's women's affairs office, Ariunzaya, the head of the Department of Obstetrics and Gynecology at the National Medical University,
and representatives of NGOs involved in cancer prevention.
During the seminar, the usefulness and user evaluations of 'CerviCARE® AI' in each hospital in the Mongolian healthcare market were presented.
The evaluation results of 'CerviCARE® AI' over a period of about 5 months proved that it not only has high sensitivity in tests but also requires short and simple testing time,
making it highly useful for mass screenings. On the 24th, the Mongolian National Broadcaster (MNB) introduced the free screening services and
utilization cases of 'CerviCARE® AI' conducted in remote areas of Mongolia, focusing on the innovative nature of 'CerviCARE® AI'.
The broadcast introduced NTL Healthcare as a leading company in femtech that constantly challenges itself to provide various screening services,
including the cervical cancer and other women's cancers. Also, NTL has signed an MOU with the Mongolian National Railway Corporation and plans
to conduct the 'CerviCARE® AI' screening project for 6,000 female employees of the railway corporation over a period of two years until 2025.
Through the AI cervical cancer screening system, 'CerviCARE® AI', NTL aims to support the health and prevention of cervical cancer
among women workers of the Mongolian National Railway Corporation.
NTL Healthcare's AI cervical cancer screening system, 'CerviCARE® AI', was recently featured in the international scientific journal Scientific Reports,
a sister journal of Nature, with the topic of 'Improving Early Detection of Cervical Cancer'. According to the published paper, 'CerviCARE® AI' analyzes
captured cervical images in less than 5 seconds (1), rapidly distinguishing between normal and abnormal cases, and demonstrated remarkable results
with a 98% sensitivity (2) for high-grade cervical lesions.
NTL Healthcare is committed to various social contribution activities to ensure that women worldwide can easily and economically access screening services,
regardless of borders or regions. Taehee Kim, the CEO of NTL Healthcare, stated through this collaboration with Mongolia, 'As a femtech company responsible
for women's health and promoting social coexistence, we will continue to practice sharing and caring for the health of women around the world.'
Ref: 1) Test Report, Standard Bank, 2023
Ref: 2) Scientific Reports, 2024
The artificial intelligence (AI) cervical cancer screening system, 'CerviCARE® AI', provided worldwide by NTL Healthcare, was a major topic of discussion.
The seminar was successfully held with the attendance of the director of the National Cancer Center and current member of the National Assembly, Chinburen,
the head of the ruling party's women's affairs office, Ariunzaya, the head of the Department of Obstetrics and Gynecology at the National Medical University,
and representatives of NGOs involved in cancer prevention.
During the seminar, the usefulness and user evaluations of 'CerviCARE® AI' in each hospital in the Mongolian healthcare market were presented.
The evaluation results of 'CerviCARE® AI' over a period of about 5 months proved that it not only has high sensitivity in tests but also requires short and simple testing time,
making it highly useful for mass screenings. On the 24th, the Mongolian National Broadcaster (MNB) introduced the free screening services and
utilization cases of 'CerviCARE® AI' conducted in remote areas of Mongolia, focusing on the innovative nature of 'CerviCARE® AI'.
The broadcast introduced NTL Healthcare as a leading company in femtech that constantly challenges itself to provide various screening services,
including the cervical cancer and other women's cancers. Also, NTL has signed an MOU with the Mongolian National Railway Corporation and plans
to conduct the 'CerviCARE® AI' screening project for 6,000 female employees of the railway corporation over a period of two years until 2025.
Through the AI cervical cancer screening system, 'CerviCARE® AI', NTL aims to support the health and prevention of cervical cancer
among women workers of the Mongolian National Railway Corporation.
NTL Healthcare's AI cervical cancer screening system, 'CerviCARE® AI', was recently featured in the international scientific journal Scientific Reports,
a sister journal of Nature, with the topic of 'Improving Early Detection of Cervical Cancer'. According to the published paper, 'CerviCARE® AI' analyzes
captured cervical images in less than 5 seconds (1), rapidly distinguishing between normal and abnormal cases, and demonstrated remarkable results
with a 98% sensitivity (2) for high-grade cervical lesions.
NTL Healthcare is committed to various social contribution activities to ensure that women worldwide can easily and economically access screening services,
regardless of borders or regions. Taehee Kim, the CEO of NTL Healthcare, stated through this collaboration with Mongolia, 'As a femtech company responsible
for women's health and promoting social coexistence, we will continue to practice sharing and caring for the health of women around the world.'
Ref: 1) Test Report, Standard Bank, 2023
Ref: 2) Scientific Reports, 2024
